23 November 2017 - The Royal Society, London
This joint event between the Genetics Society and the British Society for Genetic Medicine aims to explore the science that underpins current and potential future applications of the human genome to inform diagnostics, prognostics and personalisation of therapies.
Sessions will focus on advances in approaches to interpret an individual's genome in the context of rare disease, common complex disease and cancer alongside approaches aiming to provide more effective personalised therapies. The meeting will explore how the impact of variation within an individual's genome is leveraged from a population scale genotypic and phenotypic standpoint and how individuals are increasingly taking control of their own genomic information to inform health and lifestyle decisions.
Kaitlin Samocha, Harvard Medical School/Broad Institute, USA
Joe Marsh, University of Edinburgh
Denis Lo, Chinese University of Hong Kong
Serena Nik-Zainal, Sanger Institute, UK
Magnus Ingelman-Sundberg, Karolinska Institute, Sweden
Joe Pickrell, New York Genome Centre, USA
Deadline for submission of abstracts is 25 September.